Acacia: A model organism in yeast

Emerging Company Profile

In 1996, the 6,000 genes in the yeast genome (Saccharomyces cerevisiae) were sequenced. The majority of these genes have human counterparts, and the majority of metabolic and signaling pathways are directly or indirectly coupled to similar genetic machinery in both human and yeast systems.

Acacia Biosciences is using its yeast-based Genome Reporter Matrix (GRM) technology to identify new drug targets, determine which compounds in a library have the greatest therapeutic index, identify potential side effects of a

Read the full 805 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE